ServiziMenu principaleHome
You are here:  > Educational Opportunities > Past events > 2014 > ESO-ESSO Masterclass in Breast Cancer Surgery
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

ESO-ESSO Masterclass in Breast Cancer Surgery

30 ESCO credits

04.10.2014  -  07.10.2014

Ermatingen, Switzerland


Breast cancer


Chairs: A. Costa, IT - M. Leidenius, FI - L. Wyld, UK
Scientific Coordinator: W. Gatzemeier, IT

The ESO-ESSO Masterclass in Breast Cancer Surgery is at the cutting edge of current concepts of surgical treatment of breast cancer. The focus of the Masterclass is on evidence-based clinical practice and technical aspects of breast cancer surgery, within a multidisciplinary approach. The programme includes state-of-the-art lectures, “meet the expert”- type workshops and case presentations and discussions aiming at facilitating the interaction between participants and Teachers.

The Masterclass in Breast Cancer Surgery offers participants a qualified, comprehensive training to improve their knowledge and skills in the management, treatment and care in the field of breast cancer management.
Within the concept of a multidisciplinary approach attendees will improve in their skills in the totality of treatment of breast cancer and increase their confidence in the management of complex cases. Participants will better understand current best clinical practice and state of the art in breast cancer care.
The Masterclass will enable participants to implement evidence-based concepts and guidelines on the surgical treatment of breast cancer to individualize the care of their patients.

The Masterclass in Breast Cancer Surgery is at the cutting edge of current concepts of surgical treatment of breast cancer. The focus of the Masterclass is on evidence-based clinical practice and technical aspects of breast cancer surgery, within a multidisciplinary approach. The programme offers plenary lectures regarding state-of-the-art clinical evaluation, treatments with reference to clinical guidelines which will conclude in take-home messages. The Clinical sessions will be complemented by Tumour Board discussions.
Furthermore, participants will deliver case presentations within small groups and discuss these with the chairmen and the faculty aiming at facilitating the interaction between participants and teachers.
All participants will reside at the course venue and participation is compulsory
throughout the course. The Masterclass will be entirely in English and fluency in English is mandatory for admission

• Skin and Nipple sparing mastectomy
• Excisional margins - do they really count?
• The use of nomograms in clinical practice
• Management of borderline lesions
• Breast surgery for stage IV patients
• Conservative surgery for local recurrence
• Multidisciplinary management of DCIS
• Impact of surgery on molecular subclasses of Breast Cancers
• Breast cancer during pregnancy
• Multifocal/multicentric BC
• SLNB before/after neoadjuvant chemotherapy
• RT and breast reconstruction
• Intraoperative RT
• Microinvasive BC
• Contralateral prophylactic mastectomy
• Management of axillary nodes: AMAROS and beyond

• 3-days residential educational event
• Full immersion in breast cancer surgery
• Clinically-oriented training
• Multidisciplinary
• International faculty of top experts delivering lectures
• Meet the expert workshops and case discussions

The Masterclass in 
Breast Cancer Surgery is an
ESO-ESSO joint event




General information

Ana Galán
Education Coordinator
European Society of Surgical Oncology (ESSO)
Avenue E. Mounier 83
1200 Brussels (Belgium)
e-mail: ana.galan@essoweb.org

Rita De Martini
European School of Oncology (ESO)
Via Turati, 29
20121 Milan (Italy)
e-mail: rdemartini@eso.net

Application for CME accreditation has been made to the European Accreditation Council for Continuing Medical Education (EACCME®), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
Information on the status of the application can be obtained from the organising secretariat.

Faculty list

F. Cardoso, Breast Unit, Champalimaud Cancer Center, Lisbon, PT
A. Costa, European School of Oncology, Milan, IT
W. Gatzemeier, Breast Unit, Humanitas Cancer Center, Rozzano/Milan, IT
T. Kovacs, Breast Unit, Guy's and St. Thomas' NHS Foundation Trust, London, UK
M. Leidenius, Breast Surgery Unit, Helsinki University Central Hospital, FI
E.C. Moser, Breast Unit and Department of Radiation Oncology, Champalimaud Cancer Center, Lisbon, PT
P. Panizza, Department of Diagnostic Radiology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, IT
G. Pruneri, Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, IT
D. Rainsbury, Oncoplastic Breast Surgery, Royal Hampshire County Hospital, Winchester, UK
S. Suominen, Department of Plastic Surgery, Helsinki University Central Hospital, Helsinki, FI
M. Thill, Department of Gynecology and Obstetrics, Certified Breast Cancer Center, Agaplesion Markus, Frankfurt, DE
L. Wyld, Academic Unit of Surgical Oncology, University of Sheffield Medical School, Sheffield, UK


4 October

  Morning: Participants' arrival, airport transfers, registration  
 14:15 Warm-up session (3 groups with Chairs)
14:45  Opening
  Multidisciplinary team of breast cancer: Why is it crucial?
F. Cardoso, PT
Session 1: Screening - Prevention - Multidisciplinary management of DCIS and other high risk lesions



The role of the radiologist
P. Panizza, IT



Classification and prognostic markers
G. Pruneri, IT


  Surgical management of DCIS
M. Leidenius, FI


 Radiation treatment of DCIS
E.C. Moser, PT
16:25  Coffee break
Session 2: Microinvasive breast cancer and borderline lesions

 Microinvasive breast cancer
M. Leidenius, FI   
 17:15 Pathology
G. Pruneri, IT
 17:35 Tumour board: Sessions 1+2
 18:30  End of daily programme
 19:30 Dinner


5 October

Session 3: Breast conservative treatment (BCT)
  8:30 Margins: What does really matter?
M. Thill, DE   

Multifocal-multicentric disease and BCT
L. Wyld, UK


Molecular subtypes and surgical approach
W. Gatzemeier, IT


Radiation treatment: Essentials in BCT
E.C. Moser, PT

 10:00 Coffee break

Session 4: Locally advanced, recurrent and advanced breast cancer

 10:30 Primary systemic therapy
F. Cardoso, PT
 11:00 Surgical considerations and primary systemic therapy
W. Gatzemeier, IT
 11:20  Surgery in locally advanced and stage IV breast cancer
M. Leidenius, FI
 11:50 Surgical treatment after recurrent breast cancer
W. Gatzemeier, IT
 12:10  Tumour board: Sessions 3+4   
 13:00 Lunch
Session 5a: Breast cancer in young patients

14:00  Surgery in young women - What is different
L. Wyld, UK
 14:20  Medical treatment in young women - What is different
F. Cardoso, PT
Session 5b: Management of high risk women
 14:40 High risk women
L. Wyld, UK
 Tumour board: Session 5
 16:00  Coffee break
Session 6: Workshop - Meet the expert 1 (small groups) case presentation (cases provided by participants) and pro/cons discussion

 End of daily programme
 19:30 Dinner


6 October

Session 7: Oncoplastic surgery

 Oncoplastic breast conservation: Indications, techniques and outcomes
D. Rainsbury, UK
 9:00  Tumour board: Session 7
Session 8: Mastectomy

  9:15 Skin sparing and non-skin sparing
T. Kovacs, UK
 9:35 Nipple sparing
L. Wyld, UK
 10:00 Coffee break
 10:30 Prophylactic - bilateral and contralateral
L. Wyld, UK
Session 9: Breast reconstruction

  10:50  Critical review of implant reconstruction   
D. Rainsbury, UK
 11:10 Current practice for implant based breast reconstruction: The role of ADMS and dermal sling to improve outcomes and patient satisfaction
T. Kovacs, UK
 11:30 Flaps
S. Suominen, FI
 11:50 Postmastectomy radiotherapy and reconstruction
E.C. Moser, PT
12:10 Tumor board: Sessions 8+9
 13:00 Lunch
Session 10: axillary management

 14:00 SLNB before and after NACT
T. Kovacs, UK
 14:30 IBCSG 23 - Z011 - AMAROS and beyond
W. Gatzemeier, IT
 15:00  Axillary radiation treatment
E.C. Moser, PT
 15:30  Nomograms
M. Leidenius, FI
 16:00 Coffee break


Tumour board: Session 10


Session 11: Workshop - Meet the expert 2 (small groups) case presentation (cases provided by participants) and pro/cons discussion

 18:30 End of daily programme


7 October

Session 12: Survivor problems
 8:30 Surgical treatment of lymphedema
S. Suominen, FI
 8:50 Endocrine issues
M. Thill, DE
  9:10 Chronic pain
M. Leidenius, FI
 9:30  Late breaking news
 10:00 Coffee break
 10:30 Learning assessment test
 12:00 Close
  Transfers and departure of participants